Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy is a phase 2, randomised interventional study registered as NCT06411795 by Masonic Cancer Center, University of Minnesota, with a registry enrolment figure of 78 participants, started 2023-11-10 and due to reach its primary completion in 2027-01-01. Interventions recorded: Bupivacaine; Hydromorphone; Iopamidol; Liposomal Bupivacaine; Medical Chart Review; Questionnaire Administration; Thoracic Epidural Analgesia; Ultrasound Imaging; X-Ray Imaging. Conditions listed: Duodenal Neoplasm; Pancreatic Neoplasm. Primary outcome: Milligram morphine equivalents (MME). Pancreatic eligibility wording from the registry: "* Adult patients, age 18 and older, undergoing open pancreaticoduodenectomy at the University of Minnesota will be included in the study". Sites: United States. No results are recorded here; the registry entry is the source.